<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03310502</url>
  </required_header>
  <id_info>
    <org_study_id>CMgene</org_study_id>
    <nct_id>NCT03310502</nct_id>
  </id_info>
  <brief_title>Variation of Genes Controlling Carbohydrate and Lipid Metabolism</brief_title>
  <acronym>CMgene</acronym>
  <official_title>Variation of Genes Controlling Carbohydrate and Lipid Metabolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Eastern Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study is to investigate genes regulating glucose and lipid metabolism in subjects
      whose glucose metabolism, lipid metabolism, blood flow, or body fat distribution has been
      measured using positron emission tomography (PET), magnetic resonance imaging (MRI), magnetic
      resonance spectroscopy (MRS) or computed tomography (CT) as part of their previous
      participation in clinical trials conducted at Turku PET Centre.

      By combining information from PET, MRI, CT, proteomics, metabolomics and genetics analyses we
      aim to find connection between genetic variation and metabolic and cardiovascular disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The data is collected as a separate part of the clinical imaging study protocols using a
      separate inform consent approved by the local ethics committee. The participation for this
      study consists of drawing whole blood, serum and plasma samples for genetics, proteomics and
      metabolomics analyses. The results from these studies are combined with baseline data from
      the original clinical imaging studies to find connections between genetic variation,
      metabolism, blood flow and body fat distribution in a cross-sectional setting.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 17, 2002</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Skeletal muscle insulin sensitivity</measure>
    <time_frame>Baseline</time_frame>
    <description>Skeletal muscle glucose uptake during euglycemic-hyperinsulinemic clamp (µmol/kg tissue/min)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Whole body insulin sensitivity</measure>
    <time_frame>Baseline</time_frame>
    <description>Whole body glucose uptake during euglycemic-hyperinsulinemic clamp (µmol/kg body weight/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visceral adipose tissue insulin sensitivity to glucose uptake</measure>
    <time_frame>Baseline</time_frame>
    <description>Visceral adipose tissue glucose uptake during euglycemic-hyperinsulinemic clamp (µmol/kg tissue/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abdominal subcutaneous adipose tissue insulin sensitivity to glucose uptake</measure>
    <time_frame>Baseline</time_frame>
    <description>Abdominal subcutaneous adipose tissue glucose uptake during euglycemic-hyperinsulinemic clamp (µmol/kg tissue/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brown adipose tissue insulin sensitivity</measure>
    <time_frame>Baseline</time_frame>
    <description>Brown adipose tissue glucose uptake during euglycemic-hyperinsulinemic clamp (µmol/kg tissue/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brown adipose tissue glucose uptake during cold exposure</measure>
    <time_frame>Baseline</time_frame>
    <description>Brown adipose tissue glucose uptake during cold exposure (µmol/kg tissue/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin sensitivity of adipose tissue lipolysis</measure>
    <time_frame>Baseline</time_frame>
    <description>Plasma free fatty acid concentration during euglycemic-hyperinsulinemic clamp (mmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial insulin sensitivity</measure>
    <time_frame>Baseline</time_frame>
    <description>Myocardial glucose uptake during euglycemic-hyperinsulinemic clamp (µmol/kg tissue/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver insulin sensitivity to glucose uptake</measure>
    <time_frame>Baseline</time_frame>
    <description>Liver glucose uptake during euglycemic-hyperinsulinemic clamp (µmol/kg tissue/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endogenous glucose production</measure>
    <time_frame>Baseline</time_frame>
    <description>Endogenous glucose production during euglycemic-hyperinsulinemic clamp (µmol/kg body weight/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain insulin sensitivity to glucose uptake</measure>
    <time_frame>Baseline</time_frame>
    <description>Brain glucose uptake during euglycemic-hyperinsulinemic clamp (µmol/kg tissue/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abdominal subcutaneous adipose tissue mass</measure>
    <time_frame>Baseline</time_frame>
    <description>Abdominal subcutaneous adipose tissue mass (kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visceral adipose tissue mass</measure>
    <time_frame>Baseline</time_frame>
    <description>Visceral adipose tissue mass (kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver fat content</measure>
    <time_frame>Baseline</time_frame>
    <description>Liver fat percentage (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial fatty acid uptake</measure>
    <time_frame>Baseline</time_frame>
    <description>Myocardial fatty acid uptake at fasting state (µmol/kg tissue/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver fatty acid uptake</measure>
    <time_frame>Baseline</time_frame>
    <description>Liver fatty acid uptake at fasting state (µmol/kg tissue/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abdominal subcutaneous adipose tissue fatty acid uptake</measure>
    <time_frame>Baseline</time_frame>
    <description>Abdominal subcutaneous adipose tissue fatty acid uptake at fasting state (µmol/kg tissue/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visceral adipose tissue fatty acid uptake</measure>
    <time_frame>Baseline</time_frame>
    <description>Visceral adipose tissue fatty acid uptake at fasting state (µmol/kg tissue/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brown adipose tissue fatty acid uptake at fasting state</measure>
    <time_frame>Baseline</time_frame>
    <description>Brown adipose tissue fatty acid uptake at fasting state (µmol/kg tissue/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brown adipose tissue fatty acid uptake during cold exposure</measure>
    <time_frame>Baseline</time_frame>
    <description>Brown adipose tissue fatty acid uptake at cold exposure (µmol/kg tissue/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skeletal muscle fatty acid uptake</measure>
    <time_frame>Baseline</time_frame>
    <description>Skeletal muscle fatty acid uptake at fasting state (µmol/kg tissue/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coronary flow reserve</measure>
    <time_frame>Baseline</time_frame>
    <description>Ratio of myocardial blood flow maximum at stress (ml/g/min) vs. myocardial blood flow at rest (ml/g/min)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">2050</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Obesity</condition>
  <condition>Insulin Resistance</condition>
  <condition>Lipid Metabolism Disorders</condition>
  <condition>PreDiabetes</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood, serum, plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Study population consists of participants of previous studies measuring glucose metabolism,
        lipid metabolism, bloow flow and adiposity at Turku PET Centre. Important subgroups in this
        study population are healthy volunteers, participants with obesity, prediabetes, type 2
        diabetes or cardiovascular disease.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Previous participation of studies measuring glucose metabolism, lipid metabolism,
             bloow flow and adiposity at Turku PET Centre

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pirjo R Nuutila, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turku PET centre, TurkuUH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pirjo R Nuutila, MD, PhD</last_name>
    <phone>+35823131868</phone>
    <email>pirnuu@utu.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Miikka Honka, MSc</last_name>
    <phone>+35823132798</phone>
    <email>mjhonk@utu.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Turku PET Centre (Turku University Hospital)</name>
      <address>
        <city>Turku</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pirjo Nuutila, M.D., Ph.D.</last_name>
      <phone>+358 2 2611 868</phone>
      <email>pirnuu@utu.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2017</study_first_submitted>
  <study_first_submitted_qc>October 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 16, 2017</study_first_posted>
  <last_update_submitted>October 10, 2017</last_update_submitted>
  <last_update_submitted_qc>October 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Turku University Hospital</investigator_affiliation>
    <investigator_full_name>Pirjo Nuutila</investigator_full_name>
    <investigator_title>Professor, chief physician</investigator_title>
  </responsible_party>
  <keyword>positron emission tomography</keyword>
  <keyword>skeletal muscle</keyword>
  <keyword>liver</keyword>
  <keyword>adipose tissue</keyword>
  <keyword>brain</keyword>
  <keyword>genetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Lipid Metabolism Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Sharing individual participant data is currently forbidden according to Finnish law.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

